TEVA.TA
Teva Pharmaceutical Industries Limited
Tel AvivILAEQUITY
Healthcare
DELAYED
Last price
11,020.00
▼ 80.00 (0.72%)
MARKET · —
Price
Open
11,030.00
Prev close
11,100.00
Day high
11,070.00
Day low
10,930.00
Volume
285.21K
Market cap
$128.42B
P/E (TTM)
61.22
52W range
5,990.00 – 11,350.00
Trailing performance
Returnvs SPY
1W
+2.99%
+4.4%
1M
+15.60%
+11.9%
3M
+8.57%
+5.5%
6M
+3.57%
-7.5%
YTD
+9.22%
-3.1%
1Y
+95.22%
+75.2%
3Y
+267.70%
+193.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$128.42B
Enterprise value$141.66B
Revenue (TTM)$17.32B
Gross profit$9.08B
EBITDA$4.27B
Net income$706.00M
EPS (TTM)$1.80
Free cash flow$2.22B
Total cash$3.66B
Total debt$16.89B
Book value / share$6.65
Shares outstanding1.17B
Float1.09B
Short % of float—
Dividend yield—
Beta (5Y)0.88
Valuation & profitability ratios
Trailing P/E61.22
Forward P/E39.78
PEG ratio1.01
Price / sales—
Price / book1,656.40
EV / revenue8.18
EV / EBITDA33.19
Gross margin52.46%
Operating margin4.03%
Profit margin4.08%
Return on equity9.69%
Return on assets5.13%
Debt / equity217.79
Current ratio0.88
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $17.26B | $16.54B | $15.85B | $14.93B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $1.41B | -$1.64B | -$559.00M | -$2.35B |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $1.41B | -$1.64B | -$559.00M | -$2.35B |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $4.23B | -5.7% |
| Next quarter | — | — | $4.22B | -10.4% |
| Current year | — | — | $16.58B | -3.9% |
| Next year | — | — | $17.30B | +4.4% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.52%
Held by institutions22.99%
Institutions holding89
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
6.09M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 3, 26 | HUGHES ERIC A Officer |
— | 52.74K | — | Direct |
| Aug 3, 26 | JOVER PLACID Officer |
— | 12.83K | — | Direct |
| Aug 3, 26 | HUGHES ERIC A Officer |
SELL | 25.58K | $892.05K | Direct |
| Aug 3, 26 | JOVER PLACID Officer |
SELL | 12.83K | $447.35K | Direct |
| Jun 11, 26 | KALIF ELIYAHU SHARON Chief Financial Officer |
SELL | 106.56K | $3.63M | Direct |
| Jun 5, 26 | BARER SOL J Director |
— | 21.74K | — | Direct |
| Jun 5, 26 | LIEBERMAN GERALD M Director |
— | 14.49K | — | Direct |
| Jun 5, 26 | CRANE ROSEMARY A Director |
— | 14.49K | — | Direct |
| Jun 5, 26 | FRANCIS RICHARD D Chief Executive Officer |
— | 13.04K | — | Direct |
| Jun 5, 26 | NISEN PERRY D Director |
— | 14.49K | — | Direct |
| Jun 5, 26 | ELSTEIN AMIR Director |
— | 14.49K | — | Direct |
| Jun 5, 26 | MIGNONE ROBERTO A. Director |
— | 14.49K | — | Direct |
| Jun 5, 26 | FRANCIS RICHARD D Chief Executive Officer |
SELL | 6.15K | $211.36K | Direct |
| Jun 3, 26 | SHIELDS MATTHEW Officer |
— | 16.20K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BARER SOL J |
Director | 448.01K | Conversion of Exercise of derivative security |
CRANE ROSEMARY A |
Director | 127.74K | Conversion of Exercise of derivative security |
ELSTEIN AMIR |
Director | 2.12M | Conversion of Exercise of derivative security |
FOX CHRISTINE |
Officer | 75.01K | Conversion of Exercise of derivative security |
FRANCIS RICHARD D |
Chief Executive Officer | 1.18M | Conversion of Exercise of derivative security |
HUGHES ERIC A |
Officer | 134.88K | Conversion of Exercise of derivative security |
LIEBERMAN GERALD M |
Director | 130.15K | Conversion of Exercise of derivative security |
MIGNONE ROBERTO A. |
Director | 487.41K | Conversion of Exercise of derivative security |
NISEN PERRY D |
Director | 119.81K | Conversion of Exercise of derivative security |
SABAG MARK |
Officer | 224.94K | Sale |
Moving averages & technicals
SMA 10
10,954.00
+0.60% from price
SMA 20
10,641.75
+3.55% from price
SMA 50
10,189.48
+8.15% from price
SMA 100
10,020.26
+9.98% from price
SMA 200
9,743.89
+13.10% from price
EMA 12
10,862.76
+1.45% from price
EMA 26
10,582.45
+4.13% from price
EMA 50
10,340.60
+6.57% from price
RSI (14)
60.8
Neutral
MACD (12,26,9)
280.31
Hist 33.89
ATR (14)
252.14
2.29% of price
Realised vol 30D
37.1%
Annualised
Bollinger upper
11,536.74
20, 2σ
Bollinger lower
9,746.76
20, 2σ
50 / 200 cross
Golden
10,189.48 vs 9,743.89
Trend bias
Above 200
+13.10%
Risk profile
Beta vs SPY
-0.65
Less volatile than market
Correlation to SPY
-0.22
Largely independent
Realised vol 30D
37.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-21.4%
Peak to trough
Max drawdown 5Y
-40.5%
Peak to trough
ATR 14
252.14
2.29% of price
Beta (reported)
0.88
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Ken de la Bastide column: Residents will be dealing with flooding for years
The Herald Bulletin, Anderson, Ind. · 5m ago
Germany's Merz to press cabinet for faster pro-growth reforms
Reuters · 10m ago
Teen killed at California high school football game; suspect arrested
USA TODAY · 17m ago
Real Madrid snatch late win at Espanyol on Mourinho's return
AFP · 21m ago
Social Security’s $184,500 Wage Cap Is Under Fire. Here’s Exactly Who Would Pay More
24/7 Wall St. · 22m ago
Maresca says Man City must fill Rodri void after Barca switch
AFP · 26m ago
ASEAN Records and ASIA Records Announce Major Expansion as Verified Record Certification Grows Across Asia
TMX Newsfile · 31m ago
Institutional Investors Are Buying Hyperliquid Strategies. Should You?
Motley Fool · 32m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.